Biomedicines announced another pharma partnership Tuesday, agreeing to work on several protein therapies with the Swiss ...

Bob Duggan’s success shows you don’t need a Ph.D., or even a college education, to make money in the complex world of biotech ...

BRAIN Biotech AG ( ETR:BNN ) shareholders will doubtless be very grateful to see the share price up 80% in the ...

A dark money anti-pharma bus —A rare disease treatment approval for Zevra —An FTC lawsuit against pharmacy benefit managers ...

As a new regime and phase begin for the market and economy, after the FED cut interest rates by a surprising 50bps last ...

Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

IPOs at three biotechs last week tempted insiders to make huge share purchases. This spilled over into buying at a couple of ...

Ginkgo Bioworks is pivoting: Once a synthetic biology darling, the flailing company has now turned to AI-driven protein ...

In celebration of Global Biotech Week, the Bioscience Association Manitoba (BAM) will host a special event at the Manitoba ...

IBBQ is a relatively new US biotech ETF that competes with established peers like IBB and XBI. Read why I don't recommend ...

The results of the study show that treatment with Carragelose eye drops for four weeks significantly improves dry eye-related symptoms by 54%. Next to excellent tolerability, patients also reported a ...

Andres Maldonado of H.C. Wainwright reiterated a Buy rating for Corbus with an $80 price target. Oppenheimer also maintained ...